| Parameter, n (%) | AEs of interest | Other AEs | SAEs | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| PID | SID | PID | SID | PID | SID | |||||||
| Patients, n (%) (N = 61) |
AEs, n | Patients, n (%) (N = 64) |
AEs, n | Patients, n (%) (N = 61) |
AEs, n | Patients, n (%) (N = 64) |
AEs, n | Patients, n (%) (N = 61) |
AEs, n | Patients, n (%) (N = 64) |
AEs, n | |
| Any AE | 11 (18.0) | 16 | 5 (7.8) | 7 | 7 (11.5) | 13 | 12 (18.8) | 13 | 1 (1.6) | 1 | 4 (6.3) | 4 |
| Severity of AE | ||||||||||||
| Mild | 8 (13.1) | 11 | 3 (4.7) | 3 | 5 (8.2) | 7 | 5 (7.8) | 6 | 0 | 0 | 0 | 0 |
| Moderate | 3 (4.9) | 4 | 2 (3.1) | 4 | 2 (3.3) | 6 | 4 (6.3) | 4 | 0 | 0 | 1 (1.6) | 1 |
| Severe | 1 (1.6) | 1 | 0 | 0 | 0 | 0 | 3 (4.7) | 3 | 1 (1.6) | 1 | 3 (4.7) | 3 |
| AEs considered related to Ig20Gly | ||||||||||||
| Related | 5 (8.2) | 6 | 2 (3.1) | 2 | 2 (3.3) | 2 | 1 (1.6) | 2 | 0 | 0 | 0 | 0 |
| Possibly related | 3 (4.9) | 3 | 2 (3.1) | 4 | 2 (3.3) | 2 | 2 (3.1) | 2 | 1 (1.6) | 1 | 0 | 0 |
| Probably related | 1 (1.6) | 1 | 1 (1.6) | 1 | 1 (1.6) | 1 | 1 (1.6) | 1 | 0 | 0 | 0 | 0 |